儿科贫血中的凝血异常与风险分层和风险评估的临床和实验室相关
1Department of Biomedical and Laboratory Science, Africa University, Zimbabwe.
Annals of medicine and surgery (2012)
|January 7, 2026
概括
儿童贫血可以通过破坏正常的血液静止引起严重的出血和凝固问题. 早期监测和量身定制的管理,包括实验室测试和临床症状,对有风险的儿童至关重要.
科学领域:
- 血液学 血液学 血液学
- 儿科医学 儿科医学
- 凝血科学 凝血科学
背景情况:
- 贫血影响全球40%的儿童,有不同的病因,如缺铁和慢性疾病.
- 贫血显著破坏血液静止,导致各种凝血异常 (例如,血小板缩,血小板功能障碍).
- 儿科贫血中的凝血障碍取决于病因,影响出血和血栓形成的风险.
研究的目的:
- 审查当前关于儿科贫血中凝血障碍的证据.
- 突出病理生理机制,临床表现和风险评估策略.
- 讨论个性化管理和未来的研究需求.
主要方法:
- 叙事审查综合临床和实验室证据.
- 强调整合全血细胞计数,凝血面板和血小板功能测定与临床特征.
- 专注于风险分层和管理策略.
主要成果:
- 贫血诱导的凝血异常很普遍,并因贫血类型而异.
- 临床特征与实验室评估相结合,有助于识别高风险儿童.
- 病因导向治疗和支持性静血措施是管理的关键组成部分.
结论:
- 在贫血儿童中,早期凝血监测是必不可少的.
- 整合临床和实验室标记可以改善风险分层,并指导管理.
- 为了获得最佳的儿科护理,需要标准化工具和基于证据的指导方针.
相关概念视频
Disorders of Hemostasis
2.0K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.0K
Venous Thrombosis IV: Nursing Management
192
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
192
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Pharmacokinetics in Pediatric Patients: Drug Distribution
251
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
251
Disorders of Erythrocytes
2.0K
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
2.0K
Coagulation
9.6K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
9.6K


